Why Physiologically-Regulated GLP-1 May Improve the Efficacy and Tolerability of Weight Loss Therapeutics
Time: 11:00 am
day: Day One
Details:
- Mimicking the physiologic secretion profile of GLP-1 to provide receptor agonism when it is needed, for improved efficacy and tolerability
- Targeting individual patient needs by developing a platform for several multi-agonist therapies
- Reducing treatment burden with a one-time, life-long therapy
